These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 35850099)

  • 1. DPP4 Inhibitor-Induced Bullous Pemphigoid in Patients with Diabetes and Chronic Kidney Disease: Clinical Case Series.
    Charitaki E; Damianakis N; Garbidaki A; Stamataki E; Liapis K; Papadaki A; Tzanakis I
    Nephron; 2023; 147(2):97-102. PubMed ID: 35850099
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dipeptidyl peptidase 4 inhibitors linked bullous pemphigoid in patients with type 2 diabetes mellitus: A series of 13 cases.
    Jha A; Misra A; Gupta R; Ghosh A; Tyagi K; Dutta K; Arora B; Durani S
    Diabetes Metab Syndr; 2020; 14(3):213-216. PubMed ID: 32172176
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The association of bullous pemphigoid with dipeptidyl-peptidase 4 inhibitors: a ten-year prospective observational study.
    Lambadiari V; Kountouri A; Kousathana F; Korakas E; Kokkalis G; Theotokoglou S; Palaiodimou L; Katsimbri P; Ikonomidis I; Theodoropoulos K; Papadavid E
    BMC Endocr Disord; 2021 Feb; 21(1):23. PubMed ID: 33573656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of Bullous Pemphigoid With Dipeptidyl-Peptidase 4 Inhibitors in Patients With Diabetes: Estimating the Risk of the New Agents and Characterizing the Patients.
    Kridin K; Bergman R
    JAMA Dermatol; 2018 Oct; 154(10):1152-1158. PubMed ID: 30090931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dipeptidyl Peptidase-4 Inhibitor-Associated Bullous Pemphigoid.
    Tasanen K; Varpuluoma O; Nishie W
    Front Immunol; 2019; 10():1238. PubMed ID: 31275298
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decrease in eosinophils infiltrating into the skin of patients with dipeptidyl peptidase-4 inhibitor-related bullous pemphigoid.
    Chijiwa C; Takeoka S; Kamata M; Tateishi M; Fukaya S; Hayashi K; Fukuyasu A; Tanaka T; Ishikawa T; Ohnishi T; Watanabe S; Tada Y
    J Dermatol; 2018 May; 45(5):596-599. PubMed ID: 29411416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bullous pemphigoid and dipeptidyl peptidase-4 inhibitors: a meta-analysis of randomized controlled trials.
    Silverii GA; Dicembrini I; Nreu B; Montereggi C; Mannucci E; Monami M
    Endocrine; 2020 Sep; 69(3):504-507. PubMed ID: 32236820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of Risk of Bullous Pemphigoid With Initiation of Dipeptidyl Peptidase-4 Inhibitor vs Second-generation Sulfonylurea.
    Lee H; Chung HJ; Pawar A; Patorno E; Kim DH
    JAMA Dermatol; 2020 Oct; 156(10):1107-1114. PubMed ID: 32697283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bullous pemphigoid associated with dipeptidyl peptidase-4 inhibitor - A case report.
    Karthik S; Joseph PE; Babu T
    J Postgrad Med; 2019; 65(4):244-246. PubMed ID: 31535624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical features of dipeptidyl peptidase-4 inhibitor-associated bullous pemphigoid in Japan: A nationwide retrospective observational study.
    Sugiyama S; Yamamoto T; Aoyama Y
    J Dermatol; 2022 Jul; 49(7):697-702. PubMed ID: 35478414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bullous pemphigoid induced by vildagliptin: a report of three cases.
    Béné J; Jacobsoone A; Coupe P; Auffret M; Babai S; Hillaire-Buys D; Jean-Pastor MJ; Vonarx M; Vermersch A; Tronquoy AF; Gautier S
    Fundam Clin Pharmacol; 2015 Feb; 29(1):112-4. PubMed ID: 24861252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A case of bullous pemphigoid ınduced by vildagliptin.
    Keseroglu HO; Taş-Aygar G; Gönül M; Gököz O; Ersoy-Evans S
    Cutan Ocul Toxicol; 2017 Jun; 36(2):201-202. PubMed ID: 27460861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Concordance with prescribing information dosage recommendations for dipeptidyl-peptidase-4 inhibitors among type 2 diabetes mellitus patients with moderate to severe chronic kidney disease.
    Huang H; Shetty S; Bauer E; Lang K
    Curr Med Res Opin; 2018 Jun; 34(6):1021-1027. PubMed ID: 29231750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bullous pemphigoid associated with dipeptidyl peptidase-4 inhibitors: A report of five cases.
    Yoshiji S; Murakami T; Harashima SI; Ko R; Kashima R; Yabe D; Ogura M; Doi K; Inagaki N
    J Diabetes Investig; 2018 Mar; 9(2):445-447. PubMed ID: 28520234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dipeptidyl-peptidase IV inhibitors (DPP4i)-associated bullous pemphigoid: Estimating the clinical profile and exploring intraclass differences.
    Kridin K
    Dermatol Ther; 2020 Jul; 33(4):e13790. PubMed ID: 32506731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dipeptidyl peptidase-4 inhibitor-related bullous pemphigoid: A comparative study of 100 patients with bullous pemphigoid and diabetes mellitus.
    Chanprapaph K; Pratumchart N; Limtong P; Rutnin S; Sukasem C; Kungvalpivat P; Triamchaisri S; Suchonwanit P
    J Dermatol; 2021 Apr; 48(4):486-496. PubMed ID: 33543537
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gliptin-Induced Bullous Pemphigoid: Canadian Case Series of 10 Patients.
    Armanious M; AbuHilal M
    J Cutan Med Surg; 2021; 25(2):163-168. PubMed ID: 33176433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bullous pemphigoid associated with use of dipeptidyl peptidase-4 inhibitor.
    Kano Y; Kato M
    CMAJ; 2022 May; 194(20):E705. PubMed ID: 35609911
    [No Abstract]   [Full Text] [Related]  

  • 19. Lisinopril prevents bullous pemphigoid induced by dipeptidyl peptidase 4 inhibitors
    Nozawa K; Suzuki T; Kayanuma G; Yamamoto H; Nagayasu K; Shirakawa H; Kaneko S
    Front Immunol; 2022; 13():1084960. PubMed ID: 36685490
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dipeptidyl peptidase-4 inhibitors and bullous pemphigoid: A systematic review and adjusted meta-analysis.
    Phan K; Charlton O; Smith SD
    Australas J Dermatol; 2020 Feb; 61(1):e15-e21. PubMed ID: 31215644
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.